Cachet Pharmaceutical Co., Ltd. (SHE:002462)
China flag China · Delayed Price · Currency is CNY
10.13
-0.17 (-1.65%)
Nov 18, 2026, 3:05 PM CST

Cachet Pharmaceutical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
14.96111.38158.14250.06296.94353.88
Depreciation & Amortization
86.2686.26126.54202.14227201.09
Other Amortization
18.6418.6431.9378.8253.4531.25
Loss (Gain) From Sale of Assets
-4.31-4.31-201.43-0.85-1.67-0.74
Asset Writedown & Restructuring Costs
49.1349.1386.5640.3522.0913.92
Loss (Gain) From Sale of Investments
-3.57-3.570.01-0.07-0.15-1.02
Provision & Write-off of Bad Debts
247.07247.0795.6184.5577.0326.36
Other Operating Activities
11.22145.84304.69370.99378.21421.93
Change in Accounts Receivable
914.35914.352,126-601.58-2,438-655.15
Change in Inventory
224.22224.22-125.0972.78-510.71-179.78
Change in Accounts Payable
-397.95-397.95-2,4391,1301,766704.67
Change in Other Net Operating Assets
-----0.25
Operating Cash Flow
1,1611,392180.361,595-163.45913.13
Operating Cash Flow Growth
24.02%671.92%-88.70%---18.10%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-21.7-22.79-15.42-199.3-188.53-246.96
Sale of Property, Plant & Equipment
1.311.95463.276.195.793.74
Cash Acquisitions
-----1.58-
Divestitures
28.8319.5810.624.19-2.02-
Investment in Securities
-4.59-4.7-90.463.5210.9-16.24
Other Investing Activities
0.230.23-0.14-2.33
Investing Cash Flow
4.08-5.74368-185.25-175.44-257.13

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Short-Term Debt Issued
-2,3033,2435,1795,0524,242
Total Debt Issued
1,6592,3033,2435,1795,0524,242
Short-Term Debt Repaid
--3,111-3,933-5,400-4,779-4,105
Long-Term Debt Repaid
--74.52-81.9-77.33-69.48-61.85
Lease Payments
-74.52-74.52-81.9-77.33-69.48-61.85
Total Debt Repaid
-2,668-3,185-4,014-5,477-4,848-4,167
Net Debt Issued (Repaid)
-1,009-882.44-771.8-298.08203.8775.76
Repurchase of Common Stock
-6.54-6.54-10---
Common Dividends Paid
--108.87-167.57-214.34-282.31-242.66
Other Financing Activities
35.8-55.2444.66-119.07-84.39-166.23
Financing Cash Flow
-980.03-1,053-904.71-631.49-162.83-333.12

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
------0.66
Net Cash Flow
185.21333.37-356.35778.7-501.72322.22

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
1,1391,369164.931,396-351.98666.17
Free Cash Flow Growth
24.12%730.29%-88.19%---22.26%
Free Cash Flow Margin
6.61%7.01%0.69%4.65%-1.34%2.60%
Free Cash Flow Per Share
3.844.670.564.80-1.212.28
Levered Free Cash Flow
1,5491,538642.661,161-79.27359.36
Unlevered Free Cash Flow
1,5781,590723.41,26538.59462.01
Free Cash Flow After Leases
1,0651,29583.031,319-421.46604.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Interest Paid
2.722.724.292.01--
Cash Income Tax Paid
375.2361.49594.37423.62483.51557.46
Change in Working Capital
741.77741.77-421.68569.43-1,216-133.52